HJR162 — Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings

HJR162 — Encouraging the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications and report its findings · Informed CitizenryHouse Joint Resolution 162 directs the Alabama Medicaid Agency to conduct a comprehensive evaluation of the costs associated with GLP-1 (glucagon-like peptide-1) class medications. These types of d…Open in Informed Citizenry